How ready are you? Preparing for the impact of EU GMP Annex 1 on primary packaging
European Pharmaceutical Review
OCTOBER 3, 2024
Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceutical manufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety.
Let's personalize your content